Effect of histamine receptor antagonists on aminophylline-induced seizures and lethality in mice

Pharmacological Reports

Volumn 57, Issue 4, 2005, Pages 531-535

  Świader, Mariusz J ^a   Łuszczki, Jarogniew J ^a   Wielosz, Marian ^a   Czuczwar, Stanisław J ^a,b  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

Author keywords

Aminophylline induced convulsions; Antazoline; Astemizole; Cimetidine; Famotidine; Mortality

Indexed keywords

AMINOPHYLLINE; ANTAZOLINE; ANTIHISTAMINIC AGENT; ASTEMIZOLE; CIMETIDINE; FAMOTIDINE; THEOPHYLLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE PREDISPOSITION; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG MECHANISM; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; LATENT PERIOD; LETHALITY; MOUSE; NONHUMAN; SEIZURE; SEIZURE THRESHOLD; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 24744442169     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Akanuma H, Sekijima Y, Tokuda T, Takematsu H, Yanagisawa N: A case of severe status epilepticus of frontal lobe origin successfully treated with corticosteroids. Rinsho Shinkeigaku, 1998, 38, 461-464.
2. Borowicz KK, Świader M, Zgrajka W, Sawulski C, Turski WA, Czuczwar SJ: Influence of several convulsants on the protective activity of a non-competitive AMPA/kainate antagonist, LY 300164, and lamotrigine against maximal electroshock in mice. J Physiol Pharmacol, 2002, 53, 859-869.
3. Borowicz KK, Zadrozniak M, Świader M, Kowalska A, Kleinrok Z, Czuczwar SJ: Interaction of the neurosteroid alphaxalone with conventional antiepileptic drugs in different types of experimental seizures. Eur J Pharmacol, 2002, 449, 85-90.
4. Chu NS: Caffeine- and aminophylline-induced seizures. Epilepsia, 1981, 22, 85-94.
5. Członkowska AI, Krzaścik P, Sienkiewicz-Jarosz H, Siemiatkowski M, Szyndler J, Bidziński A, Płaźnik A: The effects of neurosteroids on picrotoxin-, bicuculline-and NMDA-induced seizures, and a hypnotic effect of ethanol. Pharmacol Biochem Behav, 2000, 67, 345-353.
6. Czuczwar SJ, Ikonomidou C, Kleinrok Z, Turski L, Turski W: Effect of aminophylline on the protective action of common antiepileptic drugs against electroconvulsions in mice. Epilepsia, 1986, 27, 204-208.
7. Czuczwar SJ, Jäckel R, Löscher W: Effects of aminophylline and enprofylline on the protective activity of phenobarbital against amygdala-kindled seizures in rats. Epilepsy Res, 1987, 1, 234-238.
8. Czuczwar SJ, Janusz W, Szczepanik B, Wamil A, Kleinrok Z: Effect of aminophylline upon the protective activity of common antiepileptic drugs and their plasma levels in mice. Neurosci Res, 1989, 6, 470-474.
9. Czuczwar SJ, Janusz W, Wamil A, Kleinrok Z: Inhibition of aminophylline-induced convulsions in mice by antiepileptic drugs and other agents. Eur J Pharmacol, 1987, 144, 309-315.
10. Gonzalez MA, Estes KS: Pharmacokinetic overview of oral second-generation H1 antihistamines. Int J Clin Pharmacol Ther, 1998, 36, 292-300.
11. Highland KB: Inhaled corticosteroids in chronic obstructive pulmonary disease: is there a long-term benefit? Curr Opin Pulm Med. 2004, 10, 113-119.
12. Kokate TG, Svensson BE, Rogawski MA: Anticonvulsant activity of neurosteroids: correlation with gamma-aminobutyric acid-evoked chloride current potentiation. J Pharmacol Exp Ther, 1994, 270, 1223-1229.
13. Kuna P: Current recommendation for asthma treatment. Pol Merkuriusz Lek, 2004, 16, Suppl 1, 24-29.
14. Leśkiewicz M, Budziszewska B, Jaworska-Feil L, Kubera M, Basta-Kaim A, Lasoń W: Inhibitory effect of some neuroactive steroids on cocaine-induced kindling in mice. Pol J Pharmacol, 2003, 55, 1131-1136.
15. Litchfield JT, Wilcoxon F: A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther, 1949, 96, 99-113.
16. Onodera K, Tuomisto L, Tacke U, Airaksinen M: Strain differences in regional brain histamine levels between genetically epilepsy-prone and resistant rats. Methods Find Exp Clin Pharmacol, 1992, 14, 13-16.
17. Scherkl R, Hashem A, Frey HH: Histamine in brain - its role in regulation of seizure susceptibility. Epilepsy Res, 1991, 10, 111-118.
18. Schwartz JC, Arrang JM, Garbarg M, Pollard H, Ruat M: Histaminergic transmission in the mammalian brain. Physiol Rev, 1991, 71, 1-51.
19. Świader M, Chwalczuk K, Wielosz M, Czuczwar SJ: Influence of chronic treatment with H1 receptor antagonists on the anticonvulsant activity of antiepileptic drugs. Pol J Pharmacol, 2001, 53, 93-96.
20. Świader M, Kuźniar H, Kleinrok Z, Czuczwar SJ: Influence of LY 300164, an AMPA/kainate receptor antagonist upon the anticonvulsant action of antiepileptic drugs against aminophylline-induced seizures in mice. Pol J Pharmacol, 2003, 55, 103-107.
21. Świader M, Wielosz M, Czuczwar SJ: Interaction of astemizole, an H1 receptor antagonist, with conventional antiepileptic drugs in mice. Pharmacol Biochem Behav, 2003, 76, 169-178.
22. Świader M, Wielosz M, Czuczwar SJ: Influence of antazoline and ketotifen on the anticonvulsant activity of conventional antiepileptics against maximal electroshock in mice. Eur Neuropsychopharmacol, 2004, 14, 307-318.
23. Tuomisto L, Tacke U: Is histamine an anticonvulsive inhibitory transmitter? Neuropharmacology, 1986, 25, 955-958.
24. Watanabe T, Yanai K: Studies on functional roles of the histaminergic neuron system by using pharmacological agents, knockout mice and positron emission tomography. Tohoku J Exp Med, 2001, 195, 197-217.
25. Yokoyama H, Onodera K, Yagi T, Iinuma K: Therapeutic doses of theophylline exert proconvulsant effects in developing mice. Brain Dev, 1997, 19, 403-407.
26. Zwillich CW, Sutton FD, Neff TA, Cohn WM, Matthay RA, Weinberger MM: Theophylline-induced seizures in adults. Correlation with serum concentrations. Ann Intern Med, 1975, 82, 784-787.